Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (392)	9/13/2003 9:52:28 AM
From: nigel bates	Respond to of 625

This was all that I could find in the listing agreement. Exactly how it is to be interpreted, I'm not sure... ARTICLE 13 DISPUTE RESOLUTION 14 <PAGE> 13.00 The parties shall use all commercially reasonable efforts to solve any disputes which may arise under this Agreement (including without limitation, mediation and arbitration) before having recourse to litigation. And questions to CAT are unlikely to elicit much: 1.93 Neither party shall originate any publicity, news release or public announcement, written or oral, whether to the public or the press, stockholders or otherwise, referring to the terms of this Agreement, including its existence, the subject matter to which it relates, the performance under it or any of its existence, the subject matter to which it relates, the performance under it or any of its specific terms and conditions without prior approval by the other party, except as required by law. A copy of such announcement shall be provided to the other party for comment before it is made public...